Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

More than just multiple sclerosis.
Characterisation of uveitis in association with multiple sclerosis.
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale.
A microbial symbiosis factor prevents intestinal inflammatory disease.
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
Italian validation of the 12-item multiple sclerosis walking scale.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
Elan provides update post restructuring announcement of Tysabri collaboration
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis.
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
2015 Multiple Sclerosis Experts Summit.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Burden and quality of life in caregivers of persons with multiple sclerosis.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Reproduction and the risk of multiple sclerosis.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Alemtuzumab treatment of multiple sclerosis.

Pages